Advertisement

Long-term impact of bariatric surgery on glycemic control and glucose-lowering therapy for people with type 2 diabetes: population-based cohort study

Published:February 17, 2021DOI:https://doi.org/10.1016/j.soard.2021.02.015

      Highlights

      • Bariatric surgery lowers A1c in real-world clinical care.
      • Improvements are sustained for at least 6 years.
      • Benefits were greatest for younger people and those with shorter diabetes duration.
      • Therefore, efficacy results from RCTs are generalizable to routine clinical practice.

      Abstract

      Background

      Randomized controlled trials (RCTs) have demonstrated that bariatric surgery improves glycemic control among people with diabetes. However, evidence from RCTs may not be generalizable to real-world clinical care with unselected patients in routine clinical practice.

      Objectives

      To examine long-term glycemic control and glucose-lowering drug regimens following bariatric surgery for people with type 2 diabetes (T2D) in unselected patients in routine clinical practice.

      Setting

      Population-based cohort study using linked routinely collected real-world data from Ontario, Canada.

      Methods

      Individuals with T2D who were assessed for bariatric surgery at any referral center in the province between February 2010 and November 2016 were identified and divided into those who received surgery within 2 years of the initial assessment and those who did not.

      Results

      There were 3674 people who had bariatric surgery and 1335 who did not. By 2 years, people who had undergone surgery had a significantly lower HbA1C (6.3 ± 1.2 % versus 7.8 ± 1.8 %, P < .0001), and this difference persisted at 3, 4, 5, and 6 years. Even by 6 years, half of those who had undergone surgery remained on no glucose-lowering drugs, and they were nearly 6 times less likely to be on insulin than those who had not undergone surgery.

      Conclusions

      In real-world clinical care, bariatric surgery was associated with large and sustained improvements in glycemic control.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • NCD Risk Factor Collaboration
        Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants.
        Lancet. 2016; 387: 1377-1396
        • Wang Y.C.
        • McPherson K.
        • Marsh T.
        • Gortmaker S.L.
        • Brown M.
        Health and economic burden of the projected obesity trends in the USA and the UK.
        Lancet. 2011; 378: 815-825
        • Guh D.P.
        • Zhang W.
        • Bansback N.
        • Amarsi Z.
        • Birmingham C.L.
        • Anis A.H.
        The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis.
        BMC Public Health. 2009; 9: 88
        • Edqvist J.
        • Rawshani A.
        • Adiels M.
        • et al.
        BMI and mortality in patients with new-onset type 2 diabetes: a comparison with age- and sex-matched control subjects from the general population.
        Diabetes Care. 2018; 41: 485-493
        • Wharton S.
        • Lee J.
        • Christensen R.A.
        Weight loss medications in Canada - a new frontier or a repeat of past mistakes?.
        Diabetes Metab Syndr Obes. 2017; 10: 413-417
        • Brown A.
        • Guess N.
        • Dornhorst A.
        • Taheri S.
        • Frost G.
        Insulin-associated weight gain in obese type 2 diabetes mellitus patients: what can be done?.
        Diabetes Obes Metab. 2017; 10: 1655-1668
        • Kahn S.E.
        • Cooper M.E.
        • Del Prato S.
        Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.
        Lancet. 2014; 383: 1068-1083
        • Mingrone G.
        • Panunzi S.
        • De Gaetano A.
        • et al.
        Bariatric surgery versus conventional medical therapy for type 2 diabetes.
        N Engl J Med. 2012; 366: 1577-1585
        • Ikramuddin S.
        • Korner J.
        • Lee W.-J.
        • et al.
        Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
        JAMA. 2013; 309: 2240-2249
        • Liang Z.
        • Wu Q.
        • Chen B.
        • Yu P.
        • Zhao H.
        • Ouyang X.
        Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial.
        Diabetes Res Clin Pract. 2013; 101: 50-56
        • Halperin F.
        • Ding S.-A.
        • Simonson D.C.
        • et al.
        Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
        JAMA Surgery. 2014; 149: 716-726
        • Courcoulas A.P.
        • Belle S.H.
        • Neiberg R.H.
        • et al.
        Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial.
        JAMA Surgery. 2015; 150: 931-940
        • Schauer P.R.
        • Bhatt D.L.
        • Kirwan J.P.
        • et al.
        Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes.
        N Engl J Med. 2017; 376: 641-651
        • Inge T.H.
        • Laffel L.M.
        • Jenkins T.M.
        • et al.
        Comparison of surgical and medical therapy for type 2 diabetes in severely obese adolescents.
        JAMA Pediatrics. 2018; 172: 452-460
        • Lipscombe L.L.
        • Hwee J.
        • Webster L.
        • Shah B.R.
        • Booth G.L.
        • Tu K.
        Identifying diabetes cases from administrative data: a population-based validation study.
        BMC Health Services Research. 2018; 18: 316
        • Kralj B.
        Measuring "rurality" for purposes of health-care planning: an empirical measure for Ontario.
        Ont Med Rev. 2000; 67: 33-52
        • Austin P.C.
        Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.
        Communications in Statistics - Simulation and Computation. 2009; 38: 1228-1234
        • UK Prospective Diabetes Study Group
        Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
        Lancet. 1998; 352: 837-853
        • Adams T.D.
        • Davidson L.E.
        • Litwin S.E.
        • et al.
        Weight and metabolic outcomes 12 years after gastric bypass.
        N Engl J Med. 2017; 377: 1143-1155
        • Sjöström L.
        • Peltonen M.
        • Jacobson P.
        • et al.
        Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.
        JAMA. 2014; 311: 2297-2304
        • Johnson B.L.
        • Blackhurst D.W.
        • Latham B.B.
        • et al.
        Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus.
        J Am Coll Surg. 2013; 216: 545-556
        • Castellana M.
        • Procino F.
        • Biacchi E.
        • et al.
        Roux-en-Y gastric bypass vs sleeve gastrectomy for remission of type 2 diabetes.
        J Clin Endocrinol Metab. 2021; 106: 922-933
        • McTigue K.M.
        • Wellman R.
        • Nauman E.
        • et al.
        Comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass: the National Patient-Centered Clinical Research Network (PCORNet) bariatric study.
        JAMA Surgery. 2020; 155e200087
        • Lemus R.
        • Karni D.
        • Hong D.
        • Gmora S.
        • Breau R.
        • Anvari M.
        The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
        Surg Endosc. 2018; 32: 990-1001
        • Means E.S.
        • Sobieraj D.M.
        • White C.M.
        • et al.
        Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
        PLoS One. 2015; 10e0125879
        • Lee C.M.Y.
        • Woodward M.
        • Colagiuri S.
        Triple therapy combinations for the treatment of type 2 diabetes: a network meta-analysis.
        Diabetes Res Clin Pract. 2016; 116: 149-158